---
layout: post
title: "Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Southern Hemisphere Influenza Virus Vaccines; Center for Biologics Evaluation and Research (CBER) Allergen Standardization Program"
date: 2026-02-04 21:49:22 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-18185
original_published: 2025-09-19 00:00:00 +0000
significance: 8.00
---

# Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Southern Hemisphere Influenza Virus Vaccines; Center for Biologics Evaluation and Research (CBER) Allergen Standardization Program

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** September 19, 2025 00:00 UTC
**Document Number:** 2025-18185

## Summary

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/09/19/2025-18185/vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishment-of-a)
- API: https://www.federalregister.gov/api/v1/documents/2025-18185

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
